Equillium, Inc.
Equillium, Inc. (EQ) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
eq · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Equillium, Inc. (EQ) measures how much investors pay for each dollar of the company's trailing earnings. EQ's current PE ratio of N/A is calculated by dividing its stock price of $2.77 by its TTM earnings per share of -$0.20.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2017 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Equillium, Inc.You EQ | $98M | N/A | — | -$0.20 |
 Coeptis Therapeutics, Inc. COEP | $58M | N/A | — | -$2.81 |
 Cue Biopharma, Inc. CUE | $76M | N/A | — | -$8.42 |
 Fortress Biotech, Inc. FBIO | $95M | 14.98x | — | $0.24 |
 Century Therapeutics, Inc. IPSC | $184M | N/A | — | -$0.11 |
 Medicus Pharma Ltd. Common Stock MDCX | $7M | N/A | — | -$1.47 |
 NRx Pharmaceuticals, Inc. NRXP | $75M | N/A | — | -$1.34 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.24 | — | |
2024-12-31 FY2024 | — | $-0.23 | — | |
2023-12-31 FY2023 | — | $-0.38 | — | |
2022-12-31 FY2022 | — | $-1.85 | — | |
2021-12-31 FY2021 | — | $-1.35 | — | |
2020-12-31 FY2020 | — | $-1.46 | — | |
2019-12-31 FY2019 | — | $-1.47 | — | |
2018-12-31 FY2018 | — | $-1.09 | — | |
2017-12-31 FY2017 | — | $-0.19 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Equillium, Inc. (EQ) measures how much investors pay for each dollar of the company's trailing earnings. EQ's current PE ratio of N/A is calculated by dividing its stock price of $2.77 by its TTM earnings per share of -$0.20.
Frequently asked questions
EQ pe ratio · 6 questionsEQ's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.77 and TTM EPS of -$0.20. Data sourced from Financial Modeling Prep via EQ's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Equillium, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09